Effects of the protein kinase inhibitors wortmannin and KN62 on cellular radiosensitivity and radiation-activated S phase and G1/S checkpoints in normal human fibroblasts.

L Enns, D Murray, R Mirzayans
Author Information
  1. L Enns: Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada.

Abstract

Wortmannin is a potent inhibitor of phosphatidylinositol (PI) 3-kinase and PI 3-kinase-related proteins (e.g. ATM), but it does not inhibit the activity of purified calmodulin-dependent protein kinase II (CaMKII). In the present study, we compared the effects of wortmannin and the CaMKII inhibitor KN62 on the response of normal human dermal fibroblast cultures to gamma radiation. We demonstrate that wortmannin confers a phenotype on normal fibroblasts remarkably similar to that characteristic of cells homozygous for the ATM mutation. Thus wortmannin-treated normal fibroblasts exhibit increased sensitivity to radiation-induced cell killing, lack of temporary block in transition from G1 to S phase following irradiation (i.e. impaired G1/S checkpoint), and radioresistant DNA synthesis (i.e. impaired S phase checkpoint). Wortmannin-treated cultures display a diminished capacity for radiation-induced up-regulation of p53 protein and expression of p21WAF1, a p53-regulated gene involved in cell cycle arrest at the G1/S border; the treated cultures also exhibit decreased capacity for enhancement of CaMKII activity post-irradiation, known to be necessary for triggering the S phase checkpoint. We further demonstrate that KN62 confers a radioresistant DNA synthesis phenotype on normal fibroblasts and moderately potentiates their sensitivity to killing by gamma rays, without modulating G1/S checkpoint, p53 up-regulation and p21WAF1 expression following radiation exposure. We conclude that CaMKII is involved in the radiation responsive signalling pathway mediating S phase checkpoint but not in the p53-dependent pathway controlling G1/S checkpoint, and that a wortmannin-sensitive kinase functions upstream in both pathways.

References

  1. Int J Radiat Biol. 1993 Jun;63(6):725-30 [PMID: 8100259]
  2. Cell. 1992 Nov 13;71(4):587-97 [PMID: 1423616]
  3. Oncogene. 1993 Dec;8(12):3307-12 [PMID: 8247533]
  4. Int J Radiat Biol. 1994 Feb;65(2):175-84 [PMID: 7907115]
  5. Cancer Res. 1994 May 1;54(9):2419-23 [PMID: 8162590]
  6. Cancer Res. 1995 May 1;55(9):1842-6 [PMID: 7728750]
  7. Science. 1995 Jun 16;268(5217):1619-21 [PMID: 7777860]
  8. Br J Cancer. 1995 Jun;71(6):1221-30 [PMID: 7779715]
  9. Cell. 1995 Jun 16;81(6):891-904 [PMID: 7781066]
  10. Science. 1995 Jun 23;268(5218):1749-53 [PMID: 7792600]
  11. Cell. 1995 Sep 8;82(5):849-56 [PMID: 7671312]
  12. Nature. 1995 Oct 12;377(6549):552-7 [PMID: 7566157]
  13. Oncogene. 1995 Oct 19;11(8):1597-605 [PMID: 7478584]
  14. Cancer Res. 1995 Dec 15;55(24):5991-6001 [PMID: 8521380]
  15. Cancer Res. 1996 Jan 15;56(2):246-50 [PMID: 8542574]
  16. Int J Radiat Biol. 1996 Aug;70(2):151-60 [PMID: 8794844]
  17. Radiat Res. 1997 Jan;147(1):13-21 [PMID: 8989364]
  18. Mol Cell Biol. 1997 Apr;17(4):2020-9 [PMID: 9121450]
  19. Cancer Res. 1997 Sep 15;57(18):4029-35 [PMID: 9307289]
  20. EMBO J. 1998 Jan 2;17(1):159-69 [PMID: 9427750]
  21. Int J Radiat Biol. 1998 Apr;73(4):365-71 [PMID: 9587073]
  22. Science. 1998 Sep 11;281(5383):1674-7 [PMID: 9733514]
  23. Mol Carcinog. 1998 Sep;23(1):1-12 [PMID: 9766432]
  24. Clin Cancer Res. 1997 Jul;3(7):1149-56 [PMID: 9815794]
  25. Int J Radiat Biol Relat Stud Phys Chem Med. 1986 May;49(5):771-81 [PMID: 3516900]
  26. Hum Genet. 1989 May;82(2):113-7 [PMID: 2722185]
  27. Cancer Res. 1989 Oct 15;49(20):5523-9 [PMID: 2507129]
  28. J Biol Chem. 1990 Mar 15;265(8):4315-20 [PMID: 2155222]
  29. Cancer Res. 1992 Feb 1;52(3):508-14 [PMID: 1732037]
  30. J Biol Chem. 1992 Feb 5;267(4):2157-63 [PMID: 1733924]
  31. Cell. 1993 Nov 19;75(4):817-25 [PMID: 8242752]

MeSH Term

Androstadienes
Calcium-Calmodulin-Dependent Protein Kinases
Cyclin-Dependent Kinase Inhibitor p21
Cyclins
Fibroblasts
Humans
Protein Kinase Inhibitors
Radiation, Ionizing
Radiation-Sensitizing Agents
S Phase
Tumor Cells, Cultured
Tumor Suppressor Protein p53
Wortmannin

Chemicals

Androstadienes
CDKN1A protein, human
Cyclin-Dependent Kinase Inhibitor p21
Cyclins
Protein Kinase Inhibitors
Radiation-Sensitizing Agents
Tumor Suppressor Protein p53
Calcium-Calmodulin-Dependent Protein Kinases
Wortmannin

Word Cloud

Created with Highcharts 10.0.0checkpointnormalSphaseG1/SCaMKIIfibroblastseproteinkinasewortmanninKN62culturesradiationinhibitorPIATMactivityhumangammademonstrateconfersphenotypeexhibitsensitivityradiation-inducedcellkillingfollowingiimpairedradioresistantDNAsynthesiscapacityup-regulationp53expressionp21WAF1involvedpathwayWortmanninpotentphosphatidylinositol3-kinase3-kinase-relatedproteinsginhibitpurifiedcalmodulin-dependentIIpresentstudycomparedeffectsresponsedermalfibroblastremarkablysimilarcharacteristiccellshomozygousmutationThuswortmannin-treatedincreasedlacktemporaryblocktransitionG1irradiationWortmannin-treateddisplaydiminishedp53-regulatedgenecyclearrestbordertreatedalsodecreasedenhancementpost-irradiationknownnecessarytriggeringmoderatelypotentiatesrayswithoutmodulatingexposureconcluderesponsivesignallingmediatingp53-dependentcontrollingwortmannin-sensitivefunctionsupstreampathwaysEffectsinhibitorscellularradiosensitivityradiation-activatedcheckpoints

Similar Articles

Cited By